Back to Insider Trading View Full Company Profile

ANAB

MODERATE

ANAPTYSBIO, INC

CIK: 0001370053

Strong Sell (90% confidence)

Last activity: 3 days ago

Financial Metrics

As of Dec 31, 2024 (10-K)

Revenue $91.28M
Net Income -$61.66M

Insider Roster (6 total, 6 active)

Insider Buys Sells Net Value Holdings
LOUMEAU ERIC J
CHIEF LEGAL OFFICER
0 12 -$2.74M
12,835 shares
$693K
Faga Daniel
President, CEO
0 3 -$1.72M
479,344 shares
$21.43M
MULROY DENNIS
CHIEF FINANCIAL OFFICER
0 6 -$1.55M
21,852 shares
$977K
Marquet Magda
OTHER
0 2 -$531K
11,640 shares
$560K
Lizzul Paul F.
Chief Medical Officer
0 4 -$522K
42,088 shares
$1.88M
Ware J. Anthony
OTHER
0 1 -$193K
9,630 shares
$477K

Recent Transactions

SELL LOUMEAU ERIC J (CHIEF LEGAL OFFICER)

10,000 shares @ $54.00

$540K

Feb 11, 2026

Conviction: | View SEC Filing →
SELL Marquet Magda (OTHER)

9,290 shares @ $48.12

$447K

Jan 15, 2026

Conviction: | View SEC Filing →
SELL Marquet Magda (OTHER)

1,710 shares @ $48.85

$84K

Jan 15, 2026

Conviction: | View SEC Filing →
SELL Faga Daniel (President, CEO)

14,281 shares @ $44.71

$639K

Jan 8, 2026

Conviction: | View SEC Filing →
SELL Lizzul Paul F. (Chief Medical Officer)

3,650 shares @ $44.71

$163K

Jan 8, 2026

Conviction: | View SEC Filing →
SELL MULROY DENNIS (CHIEF FINANCIAL OFFICER)

2,515 shares @ $44.71

$112K

Jan 8, 2026

Conviction: | View SEC Filing →
SELL LOUMEAU ERIC J (CHIEF LEGAL OFFICER)

2,210 shares @ $44.71

$99K

Jan 8, 2026

Conviction: | View SEC Filing →
SELL Faga Daniel (President, CEO)

9,202 shares @ $45.11

$415K

Jan 7, 2026

Conviction: | View SEC Filing →
SELL LOUMEAU ERIC J (CHIEF LEGAL OFFICER)

5,281 shares @ $45.38

$240K

Jan 7, 2026

Conviction: | View SEC Filing →
SELL Lizzul Paul F. (Chief Medical Officer)

2,235 shares @ $45.11

$101K

Jan 7, 2026

Conviction: | View SEC Filing →
SELL LOUMEAU ERIC J (CHIEF LEGAL OFFICER)

2,017 shares @ $45.11

$91K

Jan 7, 2026

Conviction: | View SEC Filing →
SELL MULROY DENNIS (CHIEF FINANCIAL OFFICER)

1,908 shares @ $45.11

$86K

Jan 7, 2026

Conviction: | View SEC Filing →
SELL LOUMEAU ERIC J (CHIEF LEGAL OFFICER)

1,841 shares @ $46.13

$85K

Jan 7, 2026

Conviction: | View SEC Filing →
SELL LOUMEAU ERIC J (CHIEF LEGAL OFFICER)

500 shares @ $47.23

$24K

Jan 7, 2026

Conviction: | View SEC Filing →
SELL Faga Daniel (President, CEO)

15,309 shares @ $43.26

$662K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Lizzul Paul F. (Chief Medical Officer)

4,219 shares @ $43.26

$183K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL MULROY DENNIS (CHIEF FINANCIAL OFFICER)

3,363 shares @ $43.26

$145K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL LOUMEAU ERIC J (CHIEF LEGAL OFFICER)

2,983 shares @ $43.26

$129K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Ware J. Anthony (OTHER)

3,900 shares @ $49.58

$193K

Dec 23, 2025

Conviction: | View SEC Filing →
SELL LOUMEAU ERIC J (CHIEF LEGAL OFFICER)

10,000 shares @ $51.00

$510K

Dec 22, 2025

Conviction: | View SEC Filing →
SELL MULROY DENNIS (CHIEF FINANCIAL OFFICER)

10,000 shares @ $50.00

$500K

Dec 22, 2025

Conviction: | View SEC Filing →
SELL Lizzul Paul F. (Chief Medical Officer)

1,500 shares @ $50.00

$75K

Dec 22, 2025

Conviction: | View SEC Filing →
SELL LOUMEAU ERIC J (CHIEF LEGAL OFFICER)

141 shares @ $46.99

$7K

Dec 18, 2025

Conviction: | View SEC Filing →
SELL LOUMEAU ERIC J (CHIEF LEGAL OFFICER)

10,000 shares @ $46.00

$460K

Dec 17, 2025

Conviction: | View SEC Filing →
SELL MULROY DENNIS (CHIEF FINANCIAL OFFICER)

9,365 shares @ $44.62

$418K

Dec 16, 2025

Conviction: | View SEC Filing →
SELL LOUMEAU ERIC J (CHIEF LEGAL OFFICER)

8,305 shares @ $44.68

$371K

Dec 16, 2025

Conviction: | View SEC Filing →
SELL MULROY DENNIS (CHIEF FINANCIAL OFFICER)

6,360 shares @ $45.21

$288K

Dec 16, 2025

Conviction: | View SEC Filing →
SELL LOUMEAU ERIC J (CHIEF LEGAL OFFICER)

4,195 shares @ $45.24

$190K

Dec 16, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.